Drug Shortage Report for BRIMONIDINE P

Last updated on 2025-11-07 History
Report ID 266906
Drug Identification Number 02301334
Brand name BRIMONIDINE P
Common or Proper name BRIMONIDINE P
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.15%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-09-09
Actual start date
Estimated end date 2025-10-31
Actual end date 2025-11-04
Shortage status Resolved
Updated date 2025-11-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-11-07 French Compare
v11 2025-11-07 English Compare
v10 2025-10-15 French Compare
v9 2025-10-15 English Compare
v8 2025-10-08 French Compare
v7 2025-10-08 English Compare
v6 2025-10-01 French Compare
v5 2025-10-01 English Compare
v4 2025-09-17 French Compare
v3 2025-09-17 English Compare
v2 2025-09-10 French Compare
v1 2025-09-10 English Compare

Showing 1 to 12 of 12